Stille Q2 FY26 EBIT climbs 64.9% to SEK 27.4 million; net sales rise 49.9% to SEK 186.9 million

• Stille AB posted Q2 net profit of SEK 20.6 million, more than doubled from a year earlier; earnings per share rose to SEK 2.29.
• Net sales climbed 49.9% year on year to SEK 186.9 million, with organic growth of 26.7%.
• EBIT before non-recurring items rose 64.9% to SEK 27.4 million, lifting the EBIT margin by 1.3 percentage points to 14.6%.
• Gross margin fell 3.7 percentage points to 48.4% due to the incorporation of Surgical Holdings and a higher share of Surgical Tables.
• CEO Ulrik Berthelsen cited improved surgical instrument supply, shorter delivery times, lower backorders; acquisition pipeline review continues with added M&A resources.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stille AB published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.